Company profile
Home - Concr
Solving data to enable precision diagnostics for all.
Financial period: 1 May 2024 to 30 Apr 2025
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
SH01 | Transaction MzQ0MTI4MDk5NmFkaXF6a2N4
Published 29 Oct 2024 03:19
SH01 | Transaction MzQzNzcwMzgzMmFkaXF6a2N4
Published 30 Sep 2024 10:05
SH01 | Transaction MzQzNzcwMDkwM2FkaXF6a2N4
Published 30 Sep 2024 09:52
SH01 | Transaction MzQzNzY5ODY1OGFkaXF6a2N4
Published 30 Sep 2024 09:44
Company registered at Companies House
1 Jan 2024 to 31 Dec 2025
**Background:** Despite improvements in the treatment of Triple Negative Breast Cancer (TNBC), the cancer returns in half of the women and shockingly 40% are dead within 5 years of their initial cancer diagnosis. There is an urgent need to identify reliable biomarkers of response for chemotherapy and immunotherapy. In this study we will apply our company'...
1 Jul 2020 to 31 Mar 2023
Patients with Carcinoma of Unknown Primary (CUP) have widespread cancer at diagnosis however the specific site of origin cannot be found making it difficult to treat. CUP is a common cancer with a poor prognosis. It is the 6th most common cause of cancer death in the UK. Every day approximately 20 people are diagnosed and 30 people die from CUP (CRUK Stat...
